Upsala journal of medical sciences最新文献

{"title":"Pulmonary artery coil embolisation prevented tumour progression in a patient with advanced squamous cell lung carcinoma.","authors":"Virginija Šileikienė,&nbsp;Viktorija Gurskytė,&nbsp;Ingrida Zeleckienė,&nbsp;Elena Bernotienė,&nbsp;Sigitas Čibiras","doi":"10.1080/03009734.2020.1753863","DOIUrl":"https://doi.org/10.1080/03009734.2020.1753863","url":null,"abstract":"<p><p><b>Background:</b> Squamous cell lung carcinoma (SqCLC) is a type of non-small-cell lung cancer, accounting for 25-30% of all lung cancer cases with a median advanced stage survival of 8-11 months. Here we present a rare case of long-term survival with metastatic SqCLC following coil embolisation of the right pulmonary artery.<b>Case presentation:</b> The 49-year-old patient was diagnosed with stage IV (cT4N3M1) SqCLC in 2007 due to a biopsy-proven central malignant tumour in the right lung and bilateral mediastinal lymphadenopathy. A magnetic resonance imaging scan also revealed a metastatic lesion in the liver. Soon after the diagnosis, the patient experienced pulmonary haemorrhage, which was managed by obturating the intermediate bronchus and performing coil embolisation of the right pulmonary artery. The patient also received chemotherapy in 2007 and 2009 without radiological changes. At three different time points in years 2010-2019, biopsies of the primary tumour were taken. All showed dense connective tissue with no indication of cancer growth. In 2020, a positron emission tomography scan showed no pathological metabolic activity in the lungs and liver. Currently, the patient remains in a stable clinical condition with a good performance status.<b>Conclusion:</b> The long-term clinical benefit indicates a direct effect of coil embolisation on tumour progression. We suggest that coil embolisation of tumour-feeding arteries could be considered as a potential treatment method for patients with SqCLC.</p>","PeriodicalId":23458,"journal":{"name":"Upsala journal of medical sciences","volume":"125 3","pages":"257-261"},"PeriodicalIF":3.4,"publicationDate":"2020-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/03009734.2020.1753863","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37887911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Being born preterm or with low weight implies a risk of infertility and premature loss of ovarian function; a national register study.","authors":"Gunilla Sydsjö,&nbsp;Marie Bladh,&nbsp;Katarina Rindeborn,&nbsp;Mats Hammar,&nbsp;Heriberto Rodriguez-Martinez,&nbsp;Elizabeth Nedstrand","doi":"10.1080/03009734.2020.1770380","DOIUrl":"https://doi.org/10.1080/03009734.2020.1770380","url":null,"abstract":"<p><p><b>Background:</b> Being born with non-optimal birth characteristics has several long-term consequences on health in general but also for the individual's reproductive pattern. In premature ovarian insufficiency (POI) the follicles are depleted or dysfunctional. This results in menopause before the age of 40, and for most of the affected women, it causes infertility. The objective of this study was to evaluate the potential effects of being born with non-optimal birth characteristics on the risk of developing POI.<b>Methods:</b> This population-based cohort register study included all women born in Sweden between 1973 and 1993 who were followed until the end of 2012 (age at the end of follow-up ranged between 39 and 59). Women diagnosed with POI were compared with women without this diagnosis with respect to being born small for gestational age, preterm, or with low birth weight. Data on birth characteristics and diagnosis of POI were collected from national registers.<b>Results:</b> A total of 1,033,878 women were included. Being born small for gestational age was associated with a slightly increased odds ratio of POI with 10%. Preterm birth and low birth weight were associated with somewhat increased ORs of POI after exclusion of those born small for gestational age. Similarly, being born preterm or with a low birth weight was also found to be associated with POI to the same extent.<b>Conclusions:</b> Being born with non-optimal birth characteristics may increase the risk of premature ovarian insufficiency.</p>","PeriodicalId":23458,"journal":{"name":"Upsala journal of medical sciences","volume":"125 3","pages":"235-239"},"PeriodicalIF":3.4,"publicationDate":"2020-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/03009734.2020.1770380","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38043171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association of the <i>NEGR1</i> rs2815752 with obesity and related traits in Pakistani females.","authors":"Sobia Rana, Maha Mobin","doi":"10.1080/03009734.2020.1756996","DOIUrl":"10.1080/03009734.2020.1756996","url":null,"abstract":"<p><p><b>Introduction:</b> The variant <i>NEGR1</i> rs2815752 has recently been linked with obesity in Caucasians. However, a very limited number of studies have examined the association of the <i>NEGR1</i> rs2815752 with overweight/obesity in non-Caucasians with no such study ever performed in Pakistani population. Therefore, the present study was undertaken to seek the association of the rs2815752 with overweight, obesity, and related traits in Pakistanis.<b>Subjects and methods:</b> The study involved 112 overweight/control pairs (total 224) and 194 obese/control pairs (total 388). Anthropometric parameters were measured by employing standard procedures. Metabolic parameters were determined by biochemical assays. Behavioral information was collected through a questionnaire. The rs2815752 was genotyped via TaqMan allelic discrimination assay. Regression analyses were employed to analyze the data in SPSS software.<b>Results:</b> The study revealed significant gender-specific association of the rs2815752 with obesity (OR 3.03; CI 1.19-7.72, <i>p</i> = 0.020) and some obesity-related anomalous anthropometric traits (weight, BMI, waist circumference, hip circumference, and abdominal and supra-iliac skinfold thicknesses) in females according to dominant model (<i>h</i> = 0.023). However, no association of the rs2815752 with obesity-related behavioral and metabolic parameters was observed.<b>Conclusion:</b> The <i>NEGR1</i> rs2815752 may be associated with obese phenotype and some of the related anthropometric traits in Pakistani females.</p>","PeriodicalId":23458,"journal":{"name":"Upsala journal of medical sciences","volume":"125 3","pages":"226-234"},"PeriodicalIF":1.5,"publicationDate":"2020-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875551/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37946694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Using total plasma triacylglycerol to assess hepatic <i>de novo</i> lipogenesis as an alternative to VLDL triacylglycerol.","authors":"Leanne Hodson, Sion A Parry, Thomas Cornfield, Catriona Charlton, Wee Suan Low, Charlotte J Green, Fredrik Rosqvist","doi":"10.1080/03009734.2020.1739789","DOIUrl":"10.1080/03009734.2020.1739789","url":null,"abstract":"<p><p><b>Background:</b> Hepatic <i>de novo</i> lipogenesis (DNL) is ideally measured in very low-density lipoprotein (VLDL)-triacylglycerol (TAG). In the fasting state, the majority of plasma TAG typically represents VLDL-TAG; however, the merits of measuring DNL in total plasma TAG have not been assessed. This study aimed to assess the performance of DNL measured in VLDL-TAG (DNL_VLDL-TAG) compared to that measured in total plasma TAG (DNL_Plasma-TAG).<b>Methods:</b> Using deuterated water, newly synthesised palmitate was determined in fasting plasma VLDL-TAG and total TAG in 63 subjects taking part in multiple studies resulting in <i>n</i> = 123 assessments of DNL (%new palmitate of total palmitate). Subjects were split into tertiles to investigate if DNL_Plasma-TAG could correctly classify subjects having 'high' (top tertile) and 'low' (bottom tertile) DNL. Repeatability was assessed in a subgroup (<i>n</i> = 16) with repeat visits.<b>Results:</b> DNL_VLDL-TAG was 6.8% (IQR 3.6-10.7%) and DNL_Plasma-TAG was 7.5% (IQR 4.0%-11.0%), and the correlation between the methods was <i>r_s</i> = 0.62 (<i>p</i> < 0.0001). Bland-Altman plots demonstrated similar performance (mean difference 0.81%, <i>p</i> = 0.09); however, the agreement interval was wide (-9.6% to 11.2%). Compared to DNL_VLDL-TAG, 54% of subjects with low DNL were correctly classified, whilst 66% of subjects with high DNL were correctly classified using DNL_Plasma-TAG. Repeatability was acceptable (i.e. not different) at the group level, but the majority of subjects had an intra-individual variability over 25%.<b>Conclusion:</b> DNL in total plasma TAG performed similarly to DNL in VLDL-TAG at the group level, but there was large variability at the individual level. We suggest that plasma TAG could be useful for comparing DNL between groups.</p>","PeriodicalId":23458,"journal":{"name":"Upsala journal of medical sciences","volume":"125 3","pages":"211-216"},"PeriodicalIF":3.4,"publicationDate":"2020-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/03009734.2020.1739789","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37769054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bioactive glass S53P4 eradicates <i>Staphylococcus aureus</i> in biofilm/planktonic states <i>in vitro</i>.","authors":"Torstein Grønseth,&nbsp;Lene K Vestby,&nbsp;Live L Nesse,&nbsp;Magnus von Unge,&nbsp;Juha T Silvola","doi":"10.1080/03009734.2020.1765908","DOIUrl":"https://doi.org/10.1080/03009734.2020.1765908","url":null,"abstract":"<p><p><b>Background:</b> Increasing antimicrobial resistance to antibiotics is a substantial health threat. Bioactive glass S53P4 (BAG) has an antimicrobial effect that can reduce the use of antibiotics. The aim of this study was to evaluate the antimicrobial efficacy of BAG <i>in vitro</i> on staphylococci in biofilm and in planktonic form. Secondary aims were to investigate whether supernatant fluid primed from BAG retains the antibacterial capacity and if ciprofloxacin enhances the effect.<b>Methods:</b> BAG-S53P4 granules, <45 µm, primed in tryptic soy broth (TSB) were investigated with granules present in TSB (100 mg/mL) and after removal of granules (100, 200, and 400 mg/mL). The efficacy of BAG to eradicate <i>Staphylococcus aureus</i> biofilm <i>in vitro</i> was tested using 10 different clinical strains and 1 reference strain in three test systems: the biofilm-oriented antiseptic test based on metabolic activity, the biofilm bactericidal test based on culturing surviving bacteria, and confocal laser scanning microscopy (CLSM) combined with LIVE/DEAD staining.<b>Results<i>:</i></b> Exposure to 48 h primed BAG granules (100 mg/mL) produced bactericidal effects in 11/11 strains (<i>p</i> = 0.001), and CLSM showed reduction of viable bacteria in biofilm (<i>p</i> = 0.001). Supernatant primed 14 days, 400 mg/mL, reduced metabolic activity (<i>p</i> < 0.001), showed bactericidal effects for 11/11 strains (<i>p</i> = 0.001), and CLSM showed fewer viable bacteria (<i>p</i> = 0.001). The supernatant primed for 48 h, or in concentrations lower than 400 mg/mL at 14 days, did not completely eradicate biofilm.<b>Conclusion:</b> Direct exposure to BAG granules, or primed supernatant fluid, effectively eradicated <i>S. aureus</i> in biofilm. The anti-biofilm effect is time- and concentration-dependent. When BAG had reached its full antimicrobial effect, ciprofloxacin had no additional effect.</p>","PeriodicalId":23458,"journal":{"name":"Upsala journal of medical sciences","volume":"125 3","pages":"217-225"},"PeriodicalIF":3.4,"publicationDate":"2020-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/03009734.2020.1765908","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38061565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Long-term health of children conceived after assisted reproductive technology.","authors":"Christina Bergh,&nbsp;Ulla-Britt Wennerholm","doi":"10.1080/03009734.2020.1729904","DOIUrl":"https://doi.org/10.1080/03009734.2020.1729904","url":null,"abstract":"<p><p>The aim of this narrative review is to summarize the present knowledge on long-term outcome of children born after assisted reproductive technologies (ART). The main outcomes covered are neurodevelopment including cerebral palsy, cognitive development, attention deficit hyperactivity disorder and autism spectrum disease, growth, cardiovascular function, diabetes type 1, asthma, malignancies, and reproductive health. Results have mainly been obtained from systematic reviews/meta-analyses and large registry studies. It has been shown that children born after ART, when restricted to singletons, have a similar outcome for many health conditions as their spontaneously conceived peers. For some outcomes, particularly cardiovascular function and diabetes, studies show some higher risk for ART singletons or subgroup of ART singletons. The fast introduction of new ART techniques emphasizes the importance of continuous surveillance of children born after ART.</p>","PeriodicalId":23458,"journal":{"name":"Upsala journal of medical sciences","volume":"125 2","pages":"152-157"},"PeriodicalIF":3.4,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/03009734.2020.1729904","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37679925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Adjuvants in IVF-evidence for what works and what does not work.","authors":"Luciano Nardo, Spyridon Chouliaras","doi":"10.1080/03009734.2020.1751751","DOIUrl":"10.1080/03009734.2020.1751751","url":null,"abstract":"<p><p>The field of assisted reproductive technology is shaped and changed constantly by advances in science and cutting-edge innovations. In a quest to maximise outcomes, add-on interventions are often adopted and utilised prematurely while the principles of evidence-based medicine seem to be less strictly adhered to. In this review we will attempt to summarise the latest evidence about some of the adjuvants.</p>","PeriodicalId":23458,"journal":{"name":"Upsala journal of medical sciences","volume":"125 2","pages":"144-151"},"PeriodicalIF":1.5,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721040/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37909823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Knowledge about the impact of age on fertility: a brief review.","authors":"Ilse Delbaere,&nbsp;Sarah Verbiest,&nbsp;Tanja Tydén","doi":"10.1080/03009734.2019.1707913","DOIUrl":"https://doi.org/10.1080/03009734.2019.1707913","url":null,"abstract":"<p><p>Delayed childbearing is currently a major challenge in reproductive medicine as increased age has an important impact on successful conception, both in natural and in assisted reproduction. There is a lack of knowledge about the impact of age on fertility, even in highly educated populations. A number of initiatives have been taken to increase fertility awareness. Health care providers have been encouraged to talk with patients about their reproductive life plan (RLP) for almost a decade based on recommendations from the Centres for Disease Control and Prevention. This concept has been explored successfully in Swedish contraception counselling. A growing number of online interventions aim to raise fertility awareness. These websites or interactive tools provide relevant information for individuals and couples as they consider whether they want children, when they should have them, and how many they may wish to have. These interventions are important, because research depicts that knowledge helps people in their decision-making process. With new fertility preservations such as egg freezing now available, additional education is needed to be sure that women and couples are well informed about the cost and low success rates of this intervention.</p>","PeriodicalId":23458,"journal":{"name":"Upsala journal of medical sciences","volume":"125 2","pages":"167-174"},"PeriodicalIF":3.4,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/03009734.2019.1707913","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37564724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Gonadotropin-releasing hormone agonist for ovulation trigger - OHSS prevention and use of modified luteal phase support for fresh embryo transfer.","authors":"Juan Carlos Castillo,&nbsp;Thor Haahr,&nbsp;María Martínez-Moya,&nbsp;Peter Humaidan","doi":"10.1080/03009734.2020.1736696","DOIUrl":"https://doi.org/10.1080/03009734.2020.1736696","url":null,"abstract":"<p><p>The introduction of gonadotrophin-releasing hormone agonist (GnRHa) trigger greatly impacted modern IVF treatment. Patients at low risk of ovarian hyperstimulation syndrome (OHSS) development, undergoing fresh embryo transfer and GnRHa trigger can be offered a virtually OHSS-free treatment with non-inferior reproductive outcomes by using a modified luteal phase support in terms of small boluses of human chorionic gonadotrophin (hCG), daily recombinant luteinizing hormone LH (rLH) or GnRHa. In the OHSS risk patient, GnRHa trigger can safely be performed, followed by a 'freeze-all' policy with a minimal risk of OHSS development and high live birth rates in the subsequent frozen embryo transfer cycle. Importantly, GnRHa trigger opened the 'black box' of the luteal phase, promoting research in the most optimal steroid levels during the luteal phase. GnRHa trigger allows high-dose gonadotropin stimulation to achieve the optimal number of oocytes and embryos needed to ensure the highest chance of live birth. This review thoroughly discusses how the GnRHa trigger concept adds safety and efficacy to modern IVF in terms of OHSS prevention. Furthermore, the optimal luteal phase management after GnRHa trigger in fresh embryo transfer cycles is discussed.</p>","PeriodicalId":23458,"journal":{"name":"Upsala journal of medical sciences","volume":"125 2","pages":"131-137"},"PeriodicalIF":3.4,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/03009734.2020.1736696","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37898519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Persistent environmental endocrine-disrupting chemicals in ovarian follicular fluid and <i>in vitro</i> fertilization treatment outcome in women.","authors":"Richelle D Björvang, Pauliina Damdimopoulou","doi":"10.1080/03009734.2020.1727073","DOIUrl":"10.1080/03009734.2020.1727073","url":null,"abstract":"<p><p>Several international organizations have recently highlighted endocrine-disrupting chemicals (EDCs) as factors of concern in human reproduction. Since successful reproduction is dependent on timely and appropriate action of hormones, disruption of the endocrine system could lead to difficulties in conceiving or carrying a pregnancy to term. EDCs are chemicals that disrupt the endocrine system by activating or inhibiting receptors of the endocrine system, and/or altering hormone receptor expression; signal transduction; epigenetic marks; hormone synthesis, transport, distribution, and metabolism; and the fate of hormone-producing cells. Due to the increasing production of industrial chemicals over the past century and their lenient control, EDCs are now common contaminants in the environment. Consequently, everyone faces a life-long exposure to mixtures of chemicals, some of which have been identified as EDCs. As birth rates in humans are declining and the use of assisted reproductive technologies increasing, it is timely to consider possible effects of EDCs on human reproduction and fertility. In this review, we focus on persistent EDCs, their occurrence in ovarian follicular fluid, and associations to treatment outcomes in assisted reproduction. Our summary shows that despite being banned decades ago, mixtures of persistent EDCs are still detected in the ovarian follicular fluid, demonstrating direct exposure of oocytes to these chemicals. In addition, there are several reported associations between exposure and worse outcome in <i>in vitro</i> fertilization. Further research is therefore warranted to prove causality, which will lead towards better regulation and exposure reduction.</p>","PeriodicalId":23458,"journal":{"name":"Upsala journal of medical sciences","volume":"125 2","pages":"85-94"},"PeriodicalIF":3.4,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721012/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37673111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}